347 related articles for article (PubMed ID: 36050764)
1. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
Pan Y; Davis PB; Kaebler DC; Blankfield RP; Xu R
Cardiovasc Diabetol; 2022 Sep; 21(1):170. PubMed ID: 36050764
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
4. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
O'Connor AB; Noyes K; Holloway RG
Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
[TBL] [Abstract][Full Text] [Related]
5. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
Udall M; Harnett J; Mardekian J
J Med Econ; 2012; 15(2):361-70. PubMed ID: 22181052
[TBL] [Abstract][Full Text] [Related]
6. The risk of fragility fractures following initiation of gabapentin and pregabalin-A Danish, nationwide, high-dimensional propensity score-matched cohort study.
Jørgensen EB; Overgaard LK; Folkestad L; Damkier P; Hallas J; Henriksen DP
Basic Clin Pharmacol Toxicol; 2023 May; 132(5):384-391. PubMed ID: 36526604
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
[TBL] [Abstract][Full Text] [Related]
8. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.
Athanasakis K; Petrakis I; Karampli E; Vitsou E; Lyras L; Kyriopoulos J
BMC Neurol; 2013 Jun; 13():56. PubMed ID: 23731598
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin and heart failure: A population-based study.
Ho JM; Macdonald EM; Luo J; Gomes T; Antoniou T; Mamdani MM; Juurlink DN
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1087-1092. PubMed ID: 28620909
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
[TBL] [Abstract][Full Text] [Related]
11. Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy.
Mimenza Alvarado A; Aguilar Navarro S
J Diabetes Res; 2016; 2016():4078695. PubMed ID: 26885528
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
[TBL] [Abstract][Full Text] [Related]
15. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
Guay DR
Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
19. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
